section name header

Indications

REMS


Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: hypertension, peripheral edema

GI: abdominal pain, nausea, anorexia, diarrhea, dyspepsia, flatulence, HEPATOTOXICITY, liver enzymes, vomiting

Hemat: neutropenia

Metab: weight loss

MS: arthralgia, back pain

Neuro: dizziness, weakness, circumoral paresthesia, headache

Resp: INTERSTITIAL LUNG DISEASE (ILD)

Misc: ANAPHYLAXIS

Interactions

Drug-drug:

Drug-Natural Products:

Drug-Food:

Availability

(Generic available)

Route/Dosage

US Brand Names

Exservan, Rilutek, Tiglutik

Action

  • Action may be related to:
    • Inhibition of glutamate release,
    • Inactivation of sodium channels,
    • Interference with neurotransmitter binding at receptor sites.
Therapeutic effects:
  • Extended survival or time to tracheostomy in ALS.

Classifications

Therapeutic Classification: agents for amyotrophic lateral sclerosis

Pharmacokinetics

Absorption: Well absorbed (60%) after oral administration.

Distribution: Readily penetrates brain.

Protein Binding: 96%.

Metabolism/Excretion: Highly metabolized by the liver (some metabolites are pharmacologically active); 2% excreted unchanged in urine.

Half-Life: 12 hr (after multiple doses).

Time/Action Profile

ROUTEONSETPEAKDURATION
POunknownunknownunknown



Patient/Family Teaching

Pronunciation

RIL-yoo-zole